Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

ETFAD/EADV Eczema task force 2020 position paper on diagnosis and treatment of atopic dermatitis in adults and children
Andreas Wollenberg, Stéphanie Christen-Zäch, Alain Taı̈eb, et al.
Journal of the European Academy of Dermatology and Venereology (2020) Vol. 34, Iss. 12, pp. 2717-2744
Open Access | Times Cited: 361

Showing 26-50 of 361 citing articles:

Baricitinib Safety for Events of Special Interest in Populations at Risk: Analysis from Randomised Trial Data Across Rheumatologic and Dermatologic Indications
Peter C. Taylor, Thomas Bieber, Rieke Alten, et al.
Advances in Therapy (2023) Vol. 40, Iss. 4, pp. 1867-1883
Open Access | Times Cited: 26
The immunological and structural epidermal barrier dysfunction and skin microbiome in atopic dermatitis-an update
Tubanur Çetinarslan, Lisa Kümper, Regina Fölster‐Holst
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 26
Interaction between the microbiota and the skin barrier in aging skin: a comprehensive review
Yu Ri Woo, Hei Sung Kim
Frontiers in Physiology (2024) Vol. 15
Open Access | Times Cited: 15
Unraveling Atopic Dermatitis: Insights into Pathophysiology, Therapeutic Advances, and Future Perspectives
Ashutosh Pareek, Lipika Kumari, Aaushi Pareek, et al.
Cells (2024) Vol. 13, Iss. 5, pp. 425-425
Open Access | Times Cited: 12
Combining treat‐to‐target principles and shared decision‐making: International expert consensus‐based recommendations with a novel concept for minimal disease activity criteria in atopic dermatitis
Jonathan I. Silverberg, Melinda Gooderham, Norito Katoh, et al.
Journal of the European Academy of Dermatology and Venereology (2024) Vol. 38, Iss. 11, pp. 2139-2148
Open Access | Times Cited: 12
A systematic review and meta‐analysis of nutritional and dietary interventions in randomized controlled trials for skin symptoms in children with atopic dermatitis and without food allergy: An EAACI task force report
Εmilia Vassilopoulou, Anna Comotti, Nikolaos Douladiris, et al.
Allergy (2024) Vol. 79, Iss. 7, pp. 1708-1724
Open Access | Times Cited: 10
Topical anti-inflammatory treatments for eczema: network meta-analysis
S. Lax, Eleanor Van Vogt, Bridget Candy, et al.
Cochrane library (2024) Vol. 2024, Iss. 8
Closed Access | Times Cited: 9
Ruxolitinib cream monotherapy for facial and/or neck atopic dermatitis: results from a decentralized, randomized phase 2 clinical trial
Zelma C. Chiesa Fuxench, Zhihong Lai, Yutzu Kuo, et al.
Journal of Dermatological Treatment (2025) Vol. 36, Iss. 1
Open Access | Times Cited: 1
Basic Emollients for Xerosis Cutis in Atopic Dermatitis: A Review of Clinical Studies
Andreas Wollenberg, S. Barbarot, Antonio Torrelo
International Journal of Dermatology (2025)
Open Access | Times Cited: 1
Clinical practice guidelines for the diagnosis and management of atopic dermatitis
Kanokvalai Kulthanan, Papapit Tuchinda, Rattanavalai Nitiyarom, et al.
Asian Pacific Journal of Allergy and Immunology (2021)
Open Access | Times Cited: 46
Efficacy of House Dust Mite Sublingual Immunotherapy in Patients with Atopic Dermatitis: A Randomized, Double-Blind, Placebo-Controlled Trial
Sarah Sella Langer, Renata Nahas Cardili, Janaína Michelle Lima Melo, et al.
The Journal of Allergy and Clinical Immunology In Practice (2021) Vol. 10, Iss. 2, pp. 539-549.e7
Open Access | Times Cited: 42
Moderate‐to‐severe atopic dermatitis in adolescents treated with dupilumab: A multicentre Italian real‐world experience
Luca Stingeni, Leonardo Bianchi, Elettra Antonelli, et al.
Journal of the European Academy of Dermatology and Venereology (2022) Vol. 36, Iss. 8, pp. 1292-1299
Open Access | Times Cited: 38
Unveiling the true costs and societal impacts of moderate‐to‐severe atopic dermatitis in Europe
Matthias Augustin, L. Misery, Laura von Kobyletzki, et al.
Journal of the European Academy of Dermatology and Venereology (2022) Vol. 36, Iss. S7, pp. 3-16
Open Access | Times Cited: 33
Occurrence of inflammatory bowel disease in patients with chronic inflammatory skin diseases: a cohort study
Maria C. Schneeweiss, Julien Kirchgesner, Richard Wyss, et al.
British Journal of Dermatology (2022) Vol. 187, Iss. 5, pp. 692-703
Open Access | Times Cited: 30
Itching in Atopic Dermatitis: Patient- and Physician-reported Outcomes in the German Atopic Dermatitis Registry TREATgermany
Elke Weißhaar, Philipp Bentz, Christian Apfelbacher, et al.
Acta Dermato Venereologica (2023) Vol. 103, pp. adv00854-adv00854
Open Access | Times Cited: 21
Once-Daily Crisaborole Ointment, 2%, as a Long-Term Maintenance Treatment in Patients Aged ≥ 3 Months with Mild-to-Moderate Atopic Dermatitis: A 52-Week Clinical Study
Lawrence F. Eichenfield, Richard Gower, Jinhua Xu, et al.
American Journal of Clinical Dermatology (2023) Vol. 24, Iss. 4, pp. 623-635
Open Access | Times Cited: 19
Efficacy of Roflumilast Foam, 0.3%, in Patients With Seborrheic Dermatitis
Matthew Zirwas, Zoe Draelos, Janet DuBois, et al.
JAMA Dermatology (2023) Vol. 159, Iss. 6, pp. 613-613
Open Access | Times Cited: 17
Efficacy and Safety of Dupilumab Treatment with Concomitant Topical Corticosteroids in Children Aged 6 Months to 5 Years with Severe Atopic Dermatitis
Amy S. Paller, Andreas Pinter, Lara Wine Lee, et al.
Advances in Therapy (2024) Vol. 41, Iss. 3, pp. 1046-1061
Open Access | Times Cited: 7
Efficacy, Safety, and Long-Term Disease Control of Ruxolitinib Cream Among Adolescents with Atopic Dermatitis: Pooled Results from Two Randomized Phase 3 Studies
Lawrence F. Eichenfield, Eric L. Simpson, Kim Papp, et al.
American Journal of Clinical Dermatology (2024) Vol. 25, Iss. 4, pp. 669-683
Open Access | Times Cited: 7
Emerging Biologic Therapies for the Treatment of Atopic Dermatitis
José Miguel Alvarenga, Thomas Bieber, Tiago Torres
Drugs (2024)
Open Access | Times Cited: 7
Educational and psychological interventions for managing atopic dermatitis (eczema)
Heidi Singleton, Andy Hodder, Orouba Almilaji, et al.
Cochrane library (2024) Vol. 2024, Iss. 8
Open Access | Times Cited: 6
European Task Force on Atopic Dermatitis: position on vaccination of adult patients with atopic dermatitis against COVID‐19 (SARS‐CoV‐2) being treated with systemic medication and biologics
Jacob P. Thyssen, Christian Vestergaard, S. Barbarot, et al.
Journal of the European Academy of Dermatology and Venereology (2021) Vol. 35, Iss. 5
Open Access | Times Cited: 33
Persistent eczema leads to both impaired growth and food allergy: JECS birth cohort
Kiwako Yamamoto‐Hanada, Yuichi Suzuki, Limin Yang, et al.
PLoS ONE (2021) Vol. 16, Iss. 12, pp. e0260447-e0260447
Open Access | Times Cited: 33
Flare management in atopic dermatitis: from definition to treatment
Giampiero Girolomoni, Valentina Maria Busà
Therapeutic Advances in Chronic Disease (2022) Vol. 13
Open Access | Times Cited: 27
Topical Ectoine Application in Children and Adults to Treat Inflammatory Diseases Associated with an Impaired Skin Barrier: A Systematic Review
Marion Kauth, О. В. Трусова
Dermatology and Therapy (2022) Vol. 12, Iss. 2, pp. 295-313
Open Access | Times Cited: 27

Scroll to top